Novel resistin promoter polymorphisms: Association with serum resistin level in Japanese obese individuals

被引:57
作者
Azuma, K
Oguchi, S
Matsubara, Y
Mamizuka, T
Murata, M
Kikuchi, H
Watanabe, K
Katsukawa, F
Yamazaki, H
Shimada, A
Saruta, T
机构
[1] Keio Univ, Sch Med, Sports Med Res Ctr,Div Endocrinol & Metab, Dept Internal Med,Shinjuku Ku, Tokyo 16085852, Japan
[2] Keio Univ, Sch Med, Dept Internal Med, Tokyo 108, Japan
[3] Keio Univ, Sch Med, Dept Lab Med, Tokyo 108, Japan
关键词
resistin; single nucleotide polymorphism; serum level; luciferese assay; adiposity; insulin resistance;
D O I
10.1055/s-2004-825762
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: Resistin, an adipocyte-secreted cytokine recently discovered in mice, has been proposed as a link between obesity and diabetes. We analyzed resistin gene polymorphisms and examined their association with serum resistin level and obesity phenotypes in humans. Subjects and Methods: Sixty young, obese, non-diabetic subjects taking no medication were studied. DNA sequencing and genotyping of identified single nucleotide polymorphisms were performed. Associations between polymorphisms and serum resistin level, BMI, body composition, fat distribution, and several indices of insulin sensitivity were examined. Moreover, single nucleotide polymorphisms in the promoter region were examined for their influence on resistin gene transcriptional activity using luciferase reporter vectors. Results: Ten non-coding single nucleotide polymorphisms were found. The -638G>A, -420C>G, and -358G>A polymorphisms in the promoter region showed marked linkage disequilibrium with each other, and were associated with serum resistin level; however, there was no association between these polymorphisms and parameters related to adiposity or insulin resistance. The results of luciferase assay revealed that -638G>A together with the -420C>G polymorphism influenced resistin gene transcriptional activity. Conclusion: We found that variability in the serum resistin level might be related to polymorphic variants of the promoter region of the gene.
引用
收藏
页码:564 / 570
页数:7
相关论文
共 37 条
  • [1] Correlation between serum resistin level and adiposity in obese individuals
    Azuma, K
    Katsukawa, F
    Oguchi, S
    Murata, M
    Yamazaki, H
    Shimada, A
    Saruta, T
    [J]. OBESITY RESEARCH, 2003, 11 (08): : 997 - 1001
  • [2] Resistin: molecular history and prognosis
    Banerjee, RR
    Lazar, MA
    [J]. JOURNAL OF MOLECULAR MEDICINE-JMM, 2003, 81 (04): : 218 - 226
  • [3] CHAKRAVARTI A, 1984, AM J HUM GENET, V36, P1239
  • [4] 5′ flanking variants of resistin are associated with obesity
    Engert, JC
    Vohl, MC
    Williams, SM
    Lepage, P
    Loredo-Osti, JC
    Faith, J
    Doré, C
    Renaud, Y
    Burtt, NP
    Villeneuve, A
    Hirschhorn, JN
    Altshuler, D
    Groop, LC
    Després, JP
    Gaudet, D
    Hudson, TJ
    [J]. DIABETES, 2002, 51 (05) : 1629 - 1634
  • [5] Resistin release by human adipose tissue explants in primary culture
    Fain, JN
    Cheema, PS
    Bahouth, SW
    Hiler, ML
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2003, 300 (03) : 674 - 678
  • [6] Plasma resistin levels in patients with type 1 and type 2 diabetes mellitus and in healthy controls
    Fehmann, HC
    Heyn, J
    [J]. HORMONE AND METABOLIC RESEARCH, 2002, 34 (11-12) : 671 - 673
  • [7] Circulating resistin levels in essential hypertension
    Furuhashi, Masato
    Ura, Nobuyuki
    Higashiura, Katsuhiro
    Murakami, Hideyuki
    Shimamoto, Kazuaki
    [J]. CLINICAL ENDOCRINOLOGY, 2003, 59 (04) : 507 - 510
  • [8] Humphries S, 1996, THROMB HAEMOSTASIS, V75, P567
  • [9] Jonke J, 2002, OBES RES, V10, P1
  • [10] Increased resistin blood levels are not associated with insulin resistance in patients with renal disease
    Kielstein, JT
    Becker, B
    Graf, S
    Brabant, G
    Haller, H
    Fliser, D
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2003, 42 (01) : 62 - 66